These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25315422)

  • 1. The impact of dialysis therapy on older patients with advanced chronic kidney disease: a nationwide population-based study.
    Shih CJ; Chen YT; Ou SM; Yang WC; Kuo SC; Tarng DC;
    BMC Med; 2014 Oct; 12():169. PubMed ID: 25315422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of a pre-ESRD pay-for-performance programme in advanced chronic kidney disease patients.
    Hsieh HM; Lin MY; Chiu YW; Wu PH; Cheng LJ; Jian FS; Hsu CC; Hwang SJ
    Nephrol Dial Transplant; 2017 Jul; 32(7):1184-1194. PubMed ID: 28486670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value-based evaluation of dialysis versus conservative care in older patients with advanced chronic kidney disease: a cohort study.
    Verberne WR; Dijkers J; Kelder JC; Geers ABM; Jellema WT; Vincent HH; van Delden JJM; Bos WJW
    BMC Nephrol; 2018 Aug; 19(1):205. PubMed ID: 30115028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron supplementation associates with low mortality in pre-dialyzed advanced chronic kidney disease patients receiving erythropoiesis-stimulating agents: a nationwide database analysis.
    Kuo KL; Hung SC; Liu JS; Chang YK; Hsu CC; Tarng DC
    Nephrol Dial Transplant; 2015 Sep; 30(9):1518-25. PubMed ID: 25829323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of care at the end of life among elderly patients with chronic kidney disease: patterns and predictors in a nationwide cohort study.
    Chen B; Fan VY; Chou YJ; Kuo CC
    BMC Nephrol; 2017 Jan; 18(1):36. PubMed ID: 28122500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of spironolactone on the risks of mortality and hospitalization for heart failure in pre-dialysis advanced chronic kidney disease: A nationwide population-based study.
    Tseng WC; Liu JS; Hung SC; Kuo KL; Chen YH; Tarng DC; Hsu CC
    Int J Cardiol; 2017 Jul; 238():72-78. PubMed ID: 28363684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Effects of Ketoanalogues on Mortality and Renal Outcomes in Advanced Chronic Kidney Disease Patients Receiving a Low-Protein Diet.
    Wang YC; Juan SH; Chou CL; Hsieh TC; Wu JL; Fang TC
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32899821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolidinediones and Risk of Long-Term Dialysis in Diabetic Patients with Advanced Chronic Kidney Disease: A Nationwide Cohort Study.
    Chen YH; Chiang MH; Liu JS; Chang YK; Kuo KL; Hung SC; Tai HL; Hsu CC; Tarng DC
    PLoS One; 2015; 10(6):e0129922. PubMed ID: 26083376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketoanalogue supplements reduce mortality in patients with pre-dialysis advanced diabetic kidney disease: A nationwide population-based study.
    Chen HY; Sun CY; Lee CC; Wu IW; Chen YC; Lin YH; Fang WC; Pan HC
    Clin Nutr; 2021 Jun; 40(6):4149-4160. PubMed ID: 33597108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of dialysis in patients with chronic kidney disease and new-onset atrial fibrillation: A population-based cohort study.
    Hung TW; Huang JY; Jong GP
    PLoS One; 2019; 14(9):e0222656. PubMed ID: 31536566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
    Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
    BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Early Death Among Elderly Dialysis Patients: Development and Validation of a Risk Score to Assist Shared Decision Making for Dialysis Initiation.
    Thamer M; Kaufman JS; Zhang Y; Zhang Q; Cotter DJ; Bang H
    Am J Kidney Dis; 2015 Dec; 66(6):1024-32. PubMed ID: 26123861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic Status and Mortality in Chronic Kidney Disease According to Transition Versus Nontransition to Dialysis.
    Rhee CM; Kovesdy CP; Ravel VA; Streja E; Sim JJ; You AS; Gatwood J; Amin AN; Molnar MZ; Nguyen DV; Kalantar-Zadeh K
    J Ren Nutr; 2019 Mar; 29(2):82-90. PubMed ID: 30448393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Add-on Protective Effect of Pentoxifylline in Advanced Chronic Kidney Disease Treated with Renin-Angiotensin-Aldosterone System Blockade - A Nationwide Database Analysis.
    Kuo KL; Hung SC; Liu JS; Chang YK; Hsu CC; Tarng DC
    Sci Rep; 2015 Nov; 5():17150. PubMed ID: 26612282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dialysis dependence and duration on post-coronary artery bypass grafting outcomes in patients with chronic kidney disease: A nationwide cohort study in Asia.
    Chen SW; Chang CH; Lin YS; Wu VC; Chen DY; Tsai FC; Hung MJ; Chu PH; Lin PJ; Chen TH
    Int J Cardiol; 2016 Nov; 223():65-71. PubMed ID: 27532236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-Hospital Outcomes of Patients With Advanced Chronic Kidney Disease, Dialysis, and Kidney Transplant Undergoing Spinal Fusion: Analysis of a Nationwide Database.
    Yoshihara H; Yoneoka D
    Clin Spine Surg; 2018 Nov; 31(9):400-405. PubMed ID: 30024446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease.
    Schlackow I; Kent S; Herrington W; Emberson J; Haynes R; Reith C; Wanner C; Fellström B; Gray A; Landray MJ; Baigent C; Mihaylova B;
    Heart; 2017 Dec; 103(23):1880-1890. PubMed ID: 28780579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare costs of the progression of chronic kidney disease and different dialysis techniques estimated through administrative database analysis.
    Roggeri A; Roggeri DP; Zocchetti C; Bersani M; Conte F; ;
    J Nephrol; 2017 Apr; 30(2):263-269. PubMed ID: 27165160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidisciplinary care program for advanced chronic kidney disease: reduces renal replacement and medical costs.
    Chen PM; Lai TS; Chen PY; Lai CF; Yang SY; Wu V; Chiang CK; Kao TW; Huang JW; Chiang WC; Lin SL; Hung KY; Chen YM; Chu TS; Wu MS; Wu KD; Tsai TJ
    Am J Med; 2015 Jan; 128(1):68-76. PubMed ID: 25149427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenofibrate Delays the Need for Dialysis and Reduces Cardiovascular Risk Among Patients With Advanced CKD.
    Yen CL; Fan PC; Lin MS; Lee CC; Tu KH; Chen CY; Hsiao CC; Hsu HH; Tian YC; Chang CH
    J Clin Endocrinol Metab; 2021 May; 106(6):1594-1605. PubMed ID: 33677489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.